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7 Highlights
8  A novel growth medium for culturing periodontal pathogens
9  More representative of the periodontal environment
10  Cultivates a selection of periodontal pathogens and can be used with human cell culture
11 Abstract
12 A novel microbiological medium designed to be more representative of gingival crevicular fluid. Chosen 
13 representative periodontal microorganisms showed good growth with minimal effect on human cell 
14 viability. This will enable more comparisons between different periodontitis associated organisms and 
15 their potential role in host health and systemic disease.
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17 Chronic Periodontitis (CP), an infection of the periodontium,  leading to the formation of 
18 periodontal pockets and tooth loss if untreated (1). It is the most common infectious inflammatory 
19 disease worldwide affecting humans (2)  with  45 % of English adults having at least one periodontal 
20 pocket  (3). CP is of particular interest as it can be detrimental to the health of the patient and a risk factor 
21 for myriad diseases such as Alzheimer’s, (4) cardiovascular disease (5) and diabetes mellitus (6). 
22 Subgingival bacteria are the main aetiological agents behind the inflammatory processes seen in CP and 
23 induce dysregulation of the normal oral microbiota (7) and  an increased flow of gingival crevicular fluid 
24 (GCF), an inflammatory exudate that bathes the gingival crevice and favours the growth of anaerobic 
25 periodontal microorganisms (8). A key contributor to CP is Porphyromonas gingivalis (9), however, it 
26 appears that no singular group of organism is responsible for causing CP and it is likely that polymicrobial 
27 synergy and dysbiosis of multiple periodontitis associated pathogens play a role in modulation of the 
28 disease (10). Many of these periodontitis associated pathogens are difficult to culture in vitro, which is 
29 partly compounded by the lack of available broad host growth media. Periodontal pathogens are usually 
30 fastidious anaerobes and rely on nutrients secreted by other bacteria during synergism along with specific 
31 microbial and non-microbial nutrient sources (11). The aim of this study was to develop a growth medium 
32 that can facilitate the culture of a wide selection of periodontitis associated microorganisms and enable 
33 further study of potential systemic disease links via tissue culture based investigations. With the growth 
34 requirements of many of these organisms being specifically evolved to the unique environment of the 
35 gingival crevice, emulating components of the GCF can allow a developed medium to be more 
36 representative of this environmental interface and allow more representative growth of periodontal 
37 microorganisms.
38 Bacterial strains were maintained in growth media as recommended by the manufacturer. 
39 Actinomyces israelii (NCTC 12972), Campylobacter showae (NCTC 12843), Fusobacterium nucleatum 
40 subsp. Fusiforme (11326) and Prevotella intermedia (NCTC 13070)were cultivated in anaerobic conditions 
41 (80 % N2 -10 % H2 - 10 % CO2) in a Baker-Ruskin Concept Plus anaerobic incubator (Ruskin, UK) at 37°C for 
42 48 h. P. gingivalis (NCTC 11834) was cultivated in an anaerobic incubator for 72 h. Rothia dentocariosa 
43 (10917), Streptococcus constellatus (NCTC 11325) and Streptococcus sanguinis (NCTC 7863) were 
44 cultivated in carbon rich conditions (5 % CO2) in a CO2 incubator (LEEC, UK) at 37 °C for 48 h.
45 The base medium utilised was Basal Medium Mucin (BMM) as it has successfully been shown to emulate 
46 saliva for the growth of dental plaque biofilms in an ‘artificial mouth’ system (12). The constituents of 
47 BMM contained: 2.5 g/L partially purified pig gastric mucin, 10 g/L proteose peptone, 5 g/L trypticase 
2
48 peptone, 5 g/L yeast extract, 2.5 g/L KCl, 1 mMol/L urea, 1 mMol/L arginine, 1 mg/L of haemin and 1 mg/L 
49 of menadione, all purchased from Sigma Aldrich, UK.
50 The new growth medium, Artificial Gingival Crevicular Fluid – Periodontal (AGCF-P) was composed of 
51 BMM with multiple modifications. From BMM, 1 mg/mL of haemin and menadione were omitted and 5 
52 % horse blood (TCS Biosciences) was added once cooled to 50 oC after sterilisation by autoclave. This was 
53 designed to emulate the inorganic and organic constituents of GCF which are notably similar to plasma, 
54 as infiltration and degradation of red blood cells occurring during CP (13). The pH of the medium was 
55 adjusted to reflect the actual pH of GCF during CP (7.96 ±0.1) (14). Buffering of pH was performed using 
56 the phosphate buffer system of Potassium Phosphate monobasic anhydrous and Sodium Phosphate 
57 dibasic heptahydrate. Cysteine was added as a reducing agent to further mimic the reducing capacity and 
58 support the growth of anaerobic organisms. The full composition of AGCF-P was: 10 g/L proteose 
59 peptone, 5 g/L trypticase peptone, 5 g/L yeast extract, 2.5 g/L KCl, 2.5 g/L partially purified pig gastric 
60 mucin, 0.5 g/L L-cysteine, 0.17 g/L L-arginine, 0.18 g/L L-urea, 1.68 g/L Potassium Phosphate monobasic 
61 anhydrous, 41.31 g/L Sodium Phosphate dibasic heptahydrate and 5 % horse blood. If creating solid 
62 media 12 g/L of agar no 3 was added. All reagents were procured from Sigma Aldrich, UK with the 
63 exception of trypticase peptone (Scientific Laboratory Supplies, UK) and horse blood.
64 The growth of the bacterial strains on AGCF-P agar was determined by streaking a single isolated colony 
65 onto an AGCF-P agar plate. This plate was sub-cultured again to ensure continuity and photographed (not 
66 shown). Growth of bacterial strains in liquid culture was tested by inoculating a single colony into 5 mL 
67 of AGCF-P broth and grown for the NCTC recommended duration; growth was demonstrated by 
68 inoculating an AGCF-P agar plate and further incubation. For growth curves, three overnight cultures of 
69 the chosen microorganism were adjusted to an absorbance of 1.0 ± 0.05 at 540 nm obtained using a 
70 spectrophotometer (Jenway, UK). One millilitre per 100 mL of culture was inoculated into three sterile 
71 culture flasks with liquid AGCF-P growth media equilibrated overnight. Growth was assessed at 0, 2, 4, 6, 
72 24, and 48 h or daily for 5 day for P. gingivalis and at each time point colony forming units per mL 
73 (CFU/mL) were quantified using the Miles-Misra droplet method and viability was determined (15).
74 Human Gingival Fibroblast (HGF-1) primary cells (LGC standards, UK) were cultured in Dulbecco Modified 
75 Eagle Medium (DMEM) with Glutamine and Glucose (Lonza, UK), supplemented with 10 % foetal calf 
76 serum (Lonza, UK), 50 µg/mL streptomycin (Lonza, UK) and 50 µg/mL penicillin (Lonza, UK). Immortalised 
77 Human Kidney Proximal Tubule cells (HK-2) (ATCC, UK) were cultured in 50:50 glucose free DMEM 
78 (Invitrogen, UK) and Hams F-12 medium (Lonza, UK) supplemented with 10 % foetal calf serum (Lonza, 
79 UK), 50 µg/mL streptomycin (Lonza, UK), 50 µg/mL penicillin (Lonza, UK) and 2.5 mMol glutamine (Lonza, 
80 UK). Cells were growth-arrested in serum free cell culture media, in the absence of foetal calf serum. 
81 To assess the effect of AGCF-P bacterial growth medium on mammalian cell viability, the AGCF-P medium 
82 was incubated for 5 days in anaerobic conditions without bacterial inoculation. At 0, 1, 2, 3, 4 and 5 days 
83 aliquots of the AGCF-P medium were plated out to check for bacterial contamination. Viability testing 
84 and statistical analysis was conducted as detailed in (16).
85 The growth of periodontal associated pathogens was assessed in liquid and solid AGCF-P media 
86 by inoculation or streaking with a single colony of the chosen organisms. A. israelii, C. showae, F. 
87 nucleatum subsp. Fusiforme, P. intermedia, P. gingivalis, R. dentocariosa, S. constellatus and S. sanguinis 
88 all showed good growth in liquid and solid cultures even with multiple subcultures (data not shown).
89 Growth curves of representative examples of periodontal pathogens were conducted in AGCF-P broth 
90 over 2 or 5 days for P. gingivalis, to demonstrate growth (Figure 1). All organisms reached a good level of 
91 growth after 24 h, averaging at 107 CFU/mL indicating that the media was sufficiently nutritious to 
92 support the representative selection of periodontal microorganisms.
3
93
94 Figure 1. Growth curves of periodontitis associated pathogens cultured in AGCF-P broth. A) Actinomyces israelii B) 
95 Fusobacterium nucleatum C) Parvimonas micra D) Porphyromonas gingivalis E) Streptococcus constellatus F) Streptococcus 
96 sanguinis (n=3).
97 The effect of the AGCF-P medium on the cell viability of HGF-1 (Figure 2), and HK-2 (Figure 3) was assessed 
98 by exposing the cells to 1:20 dilutions of AGCF-P supernatants incubated over a 5-day period in anaerobic 
99 conditions. Although the cell viability of HGF-1 was slightly increased (Figure 2), there was no significant 
100 effect of AGCF-P supernatants on the viability of these cells or HK-2 cells after 24 h (Figure 2A and 3A) or 
101 48 h (Figure 2B and 3B) of incubation, as compared to control cells exposed to serum-free cell culture 
102 medium only. The mild positive effect of AGCF-P on the viability of primary gingival fibroblasts can be 




106 Figure 2. Cell viability of HGF-1 cells after 24 h (A) or 48 h (B) of incubation with 1:20 dilutions of AGCF-P supernatants 
107 collected over 5 days. Viability is presented as percentage change from the control (C: cells exposed to serum-free cell culture 
108 medium) and error bars represent SEM (n=3).
109
110 Figure 3. Cell viability of HK-2 cells after 24 h (A) or 48 h (B) of incubation with 1:20 dilutions of AGCF-P supernatants collected 
111 over 5 days. Viability is presented as percentage change from the control (C: cells exposed to serum-free cell culture medium) 
112 and the error bars represent SEM (n=3).
113 Mimicking the chemical components of the physiological environment is a successful strategy 
114 that has been used to cultivate particularly fastidious or uncultivatable organisms and also can influence 
115 the bacterial products present (17). Emulating some of the elements of the GCF should allow for more 
116 representative growth of disease-related organisms as alternative nutrient sources available may 
117 stimulate regulatory changes in gene expression profiles leading to the production of environment 
118 specific bacterial products, such as metabolites and secreted proteins (18). AGCF-P has been shown to 
119 cultivate a selection of periodontal organisms and could be used to test their secreted products in human 
120 cells without the growth media confounding the results, facilitating the development of in vitro and ex 
121 vivo models of CP.  The production of more biologically relevant conditions furthers research into the 
122 pathogenesis of CP, enabling  wide-ranging comparisons between organisms  to  identify key microbial 
123 products  and their effect on the human host.
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